Chordia Therapeutics Inc. [190A.T]
TOKYO, Apr 01 (Pulse News Wire) – Chordia Therapeutics Co., Ltd. (190A.T) reported the exercise status of its ninth tranche warrants for the month of March 2026.
A total of 1,485,500 shares were delivered during the month, representing 14.39% of the outstanding warrant pool. As of the end of February 2026, there were 60,939 unexercised warrants remaining, which decreased to 46,084 by the end of March. Specific exercise activities included: - On March 2, 500 shares were transferred through warrant exercises. - On March 5, 2,000 shares were transferred via warrant exercises. - On March 10, 105 shares were transferred upon exercising 3,000 warrants. - On March 13, 2,000 shares were transferred through warrant exercises.
- On March 18, 100 shares were transferred upon exercising 1,200 warrants. - On March 24, 100 shares were transferred via warrant exercises. - On March 25, 1,650 shares were transferred through warrant exercises. - On March 27, 3,700 shares were transferred upon exercising warrants. At the end of February 2026, the total number of issued shares was 73,730,900. As per the Tokyo Stock Exchange's listing regulations and the Securities Association’s rules, the company adhered to the exercise limits, maintaining an exercise ratio of 2.15%.
🟢 Confidence: High AI-translated content.